All measurements were performed sequentially as follows (
Fig. 1): (1) LLT measurement was conducted using a LipiView interferometer as previously described.
5 The measurement area was set with the pupil placed in the center of the live video screen and the green targeting rectangle 1 mm above the inferior tear meniscus. The camera focus was then manually adjusted for the clear interferometry image of the tear film. While the participant maintained a fixation on the internal target, images were captured. The participants were allowed to blink naturally during image capture. The LLT is presented in interferometric color units (ICU), where 1 ICU corresponds to approximately 1 nm. We used a LipiView II interferometer, which displays a maximum of 100 nm in any case with an LLT of greater than 100 nm LLT, (2) the lower tear meniscus height (TMH) was evaluated using Fourier-domain optical coherence tomography (FD-OCT; RTVue; Optovue, Inc., Fremont, CA, USA) 5 minutes after LLT measurement, as previously reported.
10 Vertical 2-mm scan images at the middle of the lower eyelid were obtained two times per eye, and the TMH was measured using virtual calipers in the FD-OCT software. Tear meniscus height was defined as the distance between the upper meniscus on the cornea and the lower meniscus on the lid, (3) tear film break-up time (TBUT) was measured by applying a single fluorescein strip (Haag-Streit, Koeniz, Switzerland) to the inferior palpebral conjunctiva after instilling a drop of normal saline. The mean time for three attempts was recorded, (4) after measuring the TBUT, corneal and conjunctival staining was graded from 0 to 5 according to the Oxford staining score based on the pattern of fluorescein staining notes on slit-lamp biomicroscopy,
11 (5) Schirmer's test I was performed without topical anesthesia by placing a Schirmer strip in the midlateral portion of the lower fornix. The amount of wetting was recorded after 5 minutes, and patients were asked to keep their eyes lightly closed during the test, (6) subjective symptoms were graded on a numerical scale from 0 to 4, according to the validated 12-item Ocular Surface Disease Index (OSDI) questionnaire. The total OSDI was calculated using the following formula: OSDI = (sum of scores for all questions answered × 100)/(total number of answered questions × 4), which ranges from 0 to 100,
12 and (7) the lid margins and meibomian glands were checked for lid margin abnormalities, gland expression, and meibum quality, as previously described.
4,10,13–15 Lid margin abnormalities were scored as 0 (absent) or 1 (present) for the following parameters: vascular engorgement, plugged meibomian gland orifices, anterior or posterior displacement of the mucocutaneous junction, and irregularity of the lid margin.
4,10,13,14 The presence of an inflamed lid margin was checked. The degree of meibomian gland expressibility using firm digital pressure applied on five glands of the central third of the lower lid was graded as follows: grade 0, all five glands expressible; grade 1, three to four glands expressible; grade 2, one to two glands expressible; and grade 3, no glands expressible.
13,15 The meibum quality over eight lower lid glands was graded as follows: grade 0, clear; grade 1, cloudy; grade 2, cloudy with granular debris; and grade 3, thick, like toothpaste. Each of the eight glands of the lower eyelid was graded on a scale from 0 to 3. The scores of the eight glands were summed to obtain a total score (range, 0–24).
10,13